GameStop Issues Investor Presentation Highlighting its Progress Driving Value for All Stockholders
GRAPEVINE, Texas, May 26, 2020 (GLOBE NEWSWIRE) — GameStop Corp. (NYSE: GME) (the “Company”) today announced that it has filed […]
Lexington Realty Trust Announces Appointment of Joe Bonventre as Chief Operating Officer and Brendan Mullinix as Chief Investment Officer
NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) — Lexington Realty Trust (NYSE:LXP) (“Lexington”), a real estate investment trust (REIT) focused […]
Matinas BioPharma to Present at the Jefferies Virtual Healthcare Conference
BEDMINSTER, N.J., May 26, 2020 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that Jerome D. […]
STERIS Announces Second On-site Decontamination Solution for Respiratory Masks
U.S. FDA Grants Emergency Use AuthorizationSTERIS Creates New Decontamination Cycle that Allows Hospitals to Use Their Existing Steam SterilizersDUBLIN, IRELAND, […]
KOIOS Nootropic Beverages to be Distributed Under KeHE’s elevate™ Program
Koios announces its five flavour line of nootropic beverages have been accepted into KeHE Distributors’ elevate™ program. Based in Naperville, […]
Green Thumb Industries to Open Rise Niles on May 28, Expands to Eight Cannabis Stores in Illinois and 45 Stores in the Nation
CHICAGO and VANCOUVER, British Columbia, May 26, 2020 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb”) (CSE: GTII) (OTCQX: […]
IZEA Sales Surge Following COVID-19 Dip
Orlando, Florida, May 26, 2020 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, […]
AutoZone 3rd Quarter Same Store Sales Decrease 1.0%; EPS Decreases 10.0% to $14.39; Announces Actions in Response to COVID-19
MEMPHIS, Tenn., May 26, 2020 (GLOBE NEWSWIRE) — AutoZone, Inc. (NYSE: AZO) today reported net sales of $2.8 billion for […]
Zynerba Pharmaceuticals Announces New Two-Year Data from Open Label Extension of the Phase 2 FAB-C Trial in Patients with Fragile X at 2020 American Academy of Neurology (AAN) Science Highlights Virtual Session
– Robust Response Sustained through Two Years of Treatment with Zygel™ in Patients from Phase 2 FAB-C Trial –– Top […]
Zynerba Pharmaceuticals Announces Presentation of Phase 2 BELIEVE Safety, Efficacy and Quality of Life Data in Developmental and Epileptic Encephalopathies (DEE) at the 2020 American Academy of Neurology (AAN) Science Highlights Virtual Session
DEVON, Pa., May 26, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies […]
